Johnson & Johnson reported first-quarter sales above Wall Street’s expectations and bumped up its outlook for the year, led by strong growth of new cancer medicines and a drug for treatment-resistant depression.
www.bloomberg.com
#JampampJ #Sales #Beat #Expectations #Strong #Cancer #Medicine #Growth
J&J Sales Beat Expectations on Strong Cancer Medicine Growth
